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In the two preceding papers, it has been shown that freshly isolated 
strains of meningococcus differ not inconsiderably from those strains 
maintained in  the laboratory  on artificial media over long periods, 
and known as stock strains.  Amongst the observations which have 
been recorded is the ability of fresh strains to evoke the production of 
precipitin-containing sera  (1)  which will react  specifically with the 
type-specific substances  occurring in  these  same  fresh  strains  (2). 
This and other related observations pointing to the probability that 
the meningococcus has an antigenic complex comparable, in its essen- 
tials, to that described for other organisms--especially those of the non- 
encapsulated group (3)--are described in some detail in this and the 
following paper which deal with the isolation and analysis of some of 
the antigenic  components. 
That precipitation reactions between soluble extracts of the meningococcus and 
antimeningococcal sera  occur and  are  of some  importance  diagnostically  is  no 
new observation.  As long ago as 1906, Bruclmer and Cristeanu (4) showed that, 
while extracts  in 0.75  per cent NaC1 are but feeble precipitinogens,  extracts of 
meningococci prepared in 0.15 per cent NaOH give good precipitates on the addi- 
tion of antimeningococcal serum, but not with normal horse serum.  They showed, 
moreover, that the meningococcal extract precipitates with  antigonococcal serum 
and that the same cross-precipitation occurs when an alkaline extract of gonococci 
is  set  up  with  antimeningococcal and  antigonococcal sera.  Dopter  and  Koch 
(5)  confirmed  these  results  and  introduced  the  conception of  co-precipitins  to 
account for the cross-reactions.  They showed that when the  antimeningococcal 
serum is absorbed with whole meningococci both the specific meningococcus pre- 
cipitins and also the group precipitins, which react with the gonococcus extract, 
are removed; on the other hand, when the serum is absorbed with whole gonococci, 
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only the group precipitins are removed and the absorbed serum will still react with 
the meningococcus extract.  In the same paper they showed that the reverse is 
true and that whole gonococci remove both specific  and group precipitins from 
antigonococcal serum, while whole meningococci remove only the group precipi- 
tins.  In a subsequent paper (6), Dopter extended these observations.  He stated 
that precipitating sera can be obtained by means of intravenous injection of either 
living organisms or meningococcus extract, and that the former are often the more 
efficacious.  The titre obtained varies with the animal immunized and the strain 
used for vaccination, and is not always highest when a readily agglutinable strain 
is used.  The precipitin usually parallels  the agglutinin titre, but this is not in- 
variably the case.  He showed that cross-precipitation of antimeningococcalserum, 
often in high dilution, occurs with all members of the Gram-negative pharyngeal 
micrococcus group but that, as is the case with the gonococcus, the cross-reaction 
is due to the presence of group precipitins which can be removed by absorption 
with any member of the group, while the meningococcus alone can remove the 
specific antibodies from the serum.  He pointed out that precipitation occurs even 
at room temperature.  StiU later, Dopter (7) showed that, in general, the extract 
of each type (A,  B,  C  and D)  reacts only with  its homologous antiserum.  He 
found, however, not infrequent exceptions in which cross-precipitation occurred, 
though the titre in such cases is higher in homologous than in heterologous sera. 
Absorption of anti-A serum with either Type A organisms or extract removed the 
homologous precipitins and the same is true for the absorption of other type sera 
by their homologous strains. 
Zinsser and Parker  (8) obtained a residue antigen from the meningococcus by 
alkaline extraction of young and old broth cultures.  Przesmycki, in a brief com- 
munication (9), showed that specific residue antigens can be obtained for each of 
the four types by precipitation with five volumes of absolute alcohol.  He found 
that  these specific  antigens react most strongly with their homologous antisera, 
but  do  show  cross-precipitation  with  heterologous  sera  at  lower  titr~-results 
which correspond closely with those of Dopter.  Przesmycki made but few tests 
and himself stated that no definite conclusions could be drawn from his results. 
Recently Zozaya (10) has studied polysaccharide and protein fractions obtained 
from the different types of meningococci and compared them with fractions ob- 
tained  from pneumococci and  Gram-negative cocci.  The polysaccharide is ob- 
tained from alkaline extracts of the organisms by precipitation with four to five 
volumes of ethyl alcohol, while the nucleoprotein is isolated by 10 per cent acetic 
acid precipitation of a watery solution of organisms which have been frozen and 
thawed.  He found cross-precipitation of the polysaccharides of meningococcus, 
gonococcus and Micrococcus catarrhalis with polyvalent antimeningococcal serum 
and showed that these group precipitins could be removed by absorption of  the 
serum with any one of the three polysaccharides.  There was no  precipitation of 
the polysaccharides of pneumococcus and of Bargen's organism with  antimeningo- 
coccal serum, nor did the meningococcus polysaccharide react with  autipneumo- 
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types showed equal precipitation with polyvalent antimeningococcal  serum, and 
furthermore, absorption with  Type  I  polysaccharide removed polysaccharide 
precipitins for all types.  This polysaccharide  is, therefore,  in no way type-specific. 
The nucleoprotein was also found to be common to the group rather than type- 
specific.  It does not precipitate with sera of organisms  outside the group of Gram- 
negative cocci and absorption with nucleoprotein of Type I removes the nucleo- 
protein precipitins for all the types.  In a  further  paper (11), Zozaya found 
similarities in the polysaccharides  of the meningococcus  and certain Gram-positive 
bacilli (anthrax, trroteus,  rnesentericus  and  sub,flus).  Absorption of polyvalent 
antimeningococcal  serum with the polysaccharide  of any one of these organisms 
removes the precipitins for  the  meningococcus polysaccharide.  On  the othex 
hand,  only absorption with  anthrax  polysaccharide will remove the  anthrax 
precipitins from  anti-anthrax serum, while the other polysaccharides  are unable to 
do this.  The presence of at least two carbohydrate antibodies is presumed, one 
species-specific and the other group- or non-specific.  It is of interest to note that 
in no case was the agglutination titre of the absorbed serum altered from that of 
the unabsorbed control and  this  even when the  absorption of precipitin was 
successful. 
As this brief review of the previous studies on precipitable substances 
of the meningococcus indicates, the findings may be divided conven- 
iently into two periods.  In the first, no attention was paid to the chemi- 
cal complex of the various extracts.  The earlier investigators showed 
that alkaline extracts of the meningococcus contain precipitinogens 
which react with both antimeningococcus serum and the serum pre- 
pared against others of the Gram-negative cocci (4-6); that the anti- 
sera contain both species-specific precipitins which can be  removed 
only by the homologous organism or its extract, and group precipitins 
which can be removed by any of the organisms or their extracts (5, 6), 
and  finally, that  there  is  evidence of  the  presence  of  type-specific 
precipitinogens  as  contrasted  with  those  which  are  only  species- 
specific and common to all the meningococcus types (7).  In the later 
period, commencing with the work of Zinsser and Parker (8), endeavors 
have been made to isolate and identify the different fractions of the 
meningococcus extract which are responsible for the varying reactions 
observed.  It  has  been  shown  that  precipitation with  10  per  cent 
acetic acid will give a  nucleoprotein fraction which is species-specific 
(2,  10), while precipitation with ethyl alcohol gives at least two frac- 
tions of which one is type-specific (2, 9)  while the other is related to 
similar substances present in and obtained from other microorganisms, 
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Material and Technique 
Several methods of extracting the meningococci were tried.  These 
included  extraction  with  normal  saline  and  also  with  N/20  HC1. 
The  most  satisfactory,  as  far  as  yield  of  the  various  fractions  and 
comparative ease of separation are concerned, was that of autolysis. 
The organisms are planted in 9 cc. of beef heart infusion broth at pH 7.6.  At 
the end of 24 hours, or as soon as good growth is apparent,  the whole 9 cc. are 
planted in a liter flask containing from 700 to 900 cc. of hormone broth.  If growth 
takes place, a peUicle becomes obvious on the surface of the broth in 2 or 3 days, 
which breaks up into fine granules and gradually settles to the bottom of the medium 
when the flask is disturbed.  A new pellicle now forms on the surface and by daffy 
shaking of the flask a constant new growth may be obtained at the surface, while 
those organisms which have settled out undergo gradual autolysis at the bottom. 
Growth is maintained at 37°C. for about 2 weeks. 
The broth culture is now centrifuged at high speed to remove all debris.  The 
supernatant,  slightly cloudy fluid is measured in a  graduated cylinder and then 
placed in a liter flask.  10 cc. are taken in a test-tube, and to this is added at room 
temperature  from a burette  10 per cent acetic acid drop by drop until no more 
precipitation occurs.  A simple reckoning will permit the adding of sufficient 10 
per cent acetic acid to the bulk of the autolysate to throw out of solution the acetic 
acid-precipitable fraction.  This appears as a  greyish white deposit.  The  mix- 
ture  is  centrifuged,  the  clear  supernatant  fluid  decanted  and  the  precipitate, 
labelled P, is preserved. 
A strong solution of sodium hydroxide is added to the supernatant fluid until 
it is neutral to litmus.  It is now treated with 95 per cent ethyl alcohol.  When 
an equal volume of alcohol is added, a slight precipitate appears and this becomes 
heavy when the amount of alcohol reaches two to two and a half volumes.  This 
amount of alcohol is allowed to stand in contact with the broth solution for 24 hours 
at room temperature.  During this time a white flocculent precipitate settles out 
completely.  It is packed by centrifugation at  high speed  and  the  supernatant 
fluid decanted.  This  fraction, for reasons to be shown later, is termed the specific 
substance.  It is dried in vacuo over phosphorus pentoxide, when it forms a brown- 
ish white material somewhat like gelatin in appearance.  Most of the first pre- 
cipitate  is  insoluble  in distilled water or saline,  but all or apparently all of the 
active material goes into solution after standing in contact with distilled water or 
saline for a day or two.  The clear,  somewhat brownish solution is reprecipitated 
with two and a half volumes of 95 per cent ethyl alcohol.  The yield of this pre- 
cipitate varies between about 250 and 500 rag. of dried material from 900 cc. of 
broth.  It is dried in vacuo as before and redissolved in saline or distilled water. 
On this occasion about 90 per cent of the precipitate goes into solution; i.e.,  in 
one case 390 mg. out of 436 rag. and in another 209 mg. out of 224 mg.  The sub- 
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of sodium acetate should be added to every alternate solution-alcohol  mixture in 
order to facilitate, indeed to ensure, complete precipitation.  A standard solution 
containing 10 nag. of specific substance in 1 cc. of solution, i.e. 1/100, is made up, 
a few drops of toluol are added and it is stored in the ice box to be used  as required, 
To the supernatant fluid decanted from the specific substance precipitate are 
added another six volumes  of 95 per cent ethyl alcohol.  A heavy white precipitate 
settles out and is allowed to stand in contact with the supernatant alcohol  mixture 
for at least 24 hours at room temperature.  It is now centrifuged and the super- 
natant fluid is decanted.  The precipitate is dried over phosphorus pentoxide/n 
vacu,  o and forms a white, caked powder.  Most of this redissolves readily in water. 
It is further purified by repeated alcohol precipitation followed by resolution, 
sodium acetate being added as above.  After the first two occasions all but the 
merest trace goes back into solution.  This fraction is labelled C. 
The Type-Specific  Substances 
The fraction precipitable by means of two to two and a half volumes 
of ethyl alcohol has been obtained from Type I, Type II and Type III 
strains.  Difficulty was experienced in obtaining a strain of Type III 
organisms.  At the present time, the great majority of strains which 
occur are either Type II or belong to what may be termed the I-III 
group.  The  members of this latter  group  agglutinate equally well 
with both Type I  and Type III monovalent antisera and, as will be 
demonstrated below,  show even closer relationships when examined 
by serum absorption experiments.  There is general agreement among 
those working with this organism that, whatever may have been the 
case some years ago, at the moment great difficulty exists in separat- 
ing out two types from the I-III group, and it has been conceded that 
the strains which occur at the present  time correspond most closely 
to what was formerly termed Type I.  Some laboratories continue to 
report Type III strains, but the writer has not found such a  strain 
among the freshly isolated spinal fluid and throat strains which have 
been received.  Through the kindness of Dr. Sara Branham of Wash- 
ington, a  Type III strain  (No. 302),  isolated in 1930, was obtained. 
This is said to be the most narrowly specific Type III strain at pres- 
ent in the United States Public Health Service Department.  It has 
been used for the preparation of the Type III specific substance and 
is  fully  discussed  below.  No  freshly  isolated  strain  of  Type  IV 
meningococcus has been available up to the present time and, appar- 
ently, few, if any cases of meningitis due to this organism are occurring 
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Type I 
The type-specific substance has been obtained from several Type I 
strains.  Most  of  the  work,  however,  has  been  carried  out  on  the 
fraction  obtained  from  a  hormone-broth  autolysate  of  Strain  428 
which had grown in 900 cc. of the broth for 2 weeks.  The method of 
preparation has been described above. 
This  Strain  428 showed the characteristic agglutination of a  freshly isolated 
Type I  strain) 
The agglutination test is carried out for 2 hours at 37°C. and overnight in the 
ice box.  The readings given are the final ones.  All  the monovalent sera are 
TABLE  I 
Dilutions 
1/10 
1/2s 
1/so 
l/~S 
1/lOO 
Serum 
No. 578 
+÷+ 
+++ 
+++ 
++ 
++ 
II 
No. 551 
III 
No. 556 
+++ 
++ 
++ 
+ 
+ 
IV 
No. 535 
Saline--negative 
prepared from freshly isolated spinal fluid  strains  (1)  with the exception of the 
Type IV serum which, in the absence of any fresh strains of this type, is prepared 
from a stock strain isolated in March, 1929. 
The fraction gives a  good precipitin reaction with  homologous anti- 
sera.  Little or no difference can be found between the reaction with 
Type I  and that with Type III sera, either in the amount or the type 
All precipitin tests have been carried out in the same way.  Equal parts--0.1 cc. 
---of serum and solution of the fraction to be investigated have been placed with a 
capillary pipette in a small precipitin tube 4 to 7 ram. in diameter.  The serum is 
placed at the bottom of the tube and the solution carefully layered on top to form 
a clear line of junction.  The reading is made immediately and then after the tube 
has stood for I hour in the 37°C. water bath.  This constitutes the ring test.  The 
two fluids are then mixed and returned to the bath for 1 hour, when they are read 
again and then placed in the ice box overnight for a final reading. GEOFFREY  RAKE  AND  HENRY  W.  SCHERP  347 
of precipitate  formed.  On  the  other hand,  there is little  cross-pre- 
cipitation with Type II and  Type IV antisera,  and whatever  cross- 
precipitation exists can be removed by appropriate  absorption of the 
sera. 
Experiment 1.--A  purified  specimen of Type I  specific substance is made up 
in a dilution of 1 in 200.  This is then set up against specimens of the four mono- 
valent antisera. 1  In the first case,  the antisera have not been treated.  In the 
second case, 0.5 cc. of each of the monovalent sera has been absorbed (1) with 
0.15 cc. of packed Type II organisms,  and (2) with 5 mg. of dried C substance 
(prepared  from  Strain  23,  Type I  meningococcus).  These  absorptions  were 
carried out on separate occasions.  The organisms stood in contact with the serum 
for 18 hours at 37°C., the C substance for 12 hours at 37°C. and 12 hours in the 
ice box.  ~  The results of the precipitin experiments with both unabsorbed and 
absorbed sera are shown in Table II. 
It will be seen that  the fraction obtained from Type I  organisms 
gives  a good precipitate with homologous unabsorbed Type I  or Type 
III  sera  and  also  a  slight  precipitate  with  unabsorbed  Type  II  or 
Type IV sera.  Absorption of the sera in the manner indicated pro- 
duces a much clearer result in that it removes all the precipitins in the 
heterologous sera but leaves those in the homologous I  and  III sera 
unaffected.  In this particular experiment the Type I  serum used had 
a  rather low precipitin titre which accounts for the difference in the 
amount of precipitate formed with this serum as compared to that of 
Type III. 
It will also be noted that the type of precipitate formed with the 
homologous sera is different after absorption, being now in the form of 
a  partial  disc  whereas  formerly it  was  finely granular.  The  exact 
significance of this cannot be determined at present, but it can be said 
that  the purer  the  specimen  of specific substance  the more liability 
there is for the formation of a  partial disc or even a  true disc in the 
2 As has been the experience of other workers with other sera, it has been found 
difficult  to absorb any antimeningococcal  sera completely, no matter what the 
method employed  or  the  number  of  times  it  is  repeated.  Theoretically,  it 
should be sufficient in this particular case to absorb the sera with the heterologous 
Type II whole organisms.  In practice, however, even repeated absorption with 
these organisms fails to remove all the non-specific precipitins  in the sera and the 
additional absorption with  C substance has been found greatly to improve the 
results. 348  MENINGOCOCCUS  INFECTION.  III 
precipitin reaction.  It would seem that the  presence  of impurities 
being precipitated with the type-specific substance changes the char- 
acter of the precipitate and renders it granular. 
It might be supposed that the cross-reactions which occur between 
the  type-specific  substance  and  heterologous unabsorbed  antisera 
(not  including under this  term  the  Type III antiserum) are due to 
the presence in the purified fraction of small amounts of non-type- 
specific carbohydrate C and nucleoprotein P  fractions, and the pres- 
TABLE  II 
I 
No, 
578 
+, 
++p 
+-vp 
÷+p 
Sera unabsorbed 
II  III 
No. 
551  No. 266 
+~  +++p 
+  +++p 
+-¢-p  ++++p 
I  IV 
No. 
535 
::F:r 
-4- 
No. 578 
r 
++p 
++pd 
Seraabsorbed 
II  III 
No.  No. 266  551 
0  +" 
0  p+++~ 
0  +++pd 
0  ++++pd 
IV 
No. 
535 
o 
o 
o 
::F 
Immediate~ Ring 
1 hr.  J  test 
2 hrs. 
Ice box 
p  = granular precipitate. 
pd = disc broken up on agitation. 
=F 
± 
+ 
+* 
++ 
+++ 
++++ 
= increasing  amounts of precipitate. 
ence  in  the monovalent antisera of their  corresponding antibodies. 
This is no doubt the case to some degree, yet experiments such as Ex- 
periment 2  have  shown that  the monovalent antisera contain such 
insignificant amounts of the anti-C and anti-P antibodies that one must 
doubt whether these are altogether responsible for the cross-reactions. 
Experiment 2.--The nucleoprotein fraction (of Strain 31, Type II, purified by 
three precipitations with 10 per cent acetic acid) was made up in a standard 1/100 
solution.  A specimen of C substance (from Strain 7, Type I-III, purified by three 
precipitations with 95 per cent ethyl alcohol) was also prepared in a  dilution of GEOFFREY  RAKE  AND  HENRY  W.  SCHERP  349 
1/10o.  These two were set up with the four monovalent sera and with a specimen 
of polyvalent serum.  The results are shown in Table III. 
It will be seen from the table  that  although these group-specific 
fractions  react  strongly with the  polyvalent  serum they give only 
very slight  reactions with the monovalent sera.  With  the P  frac- 
tion indeed the reaction is only with the homologous serum and this, as 
will be shown later, is due to impurities of the type-specific substance, 
great difficulty being experienced in freeing the P fraction altogether 
from this component.  These facts suggest that the  cross-precipita- 
tion seen with some specimens of type-specific substances may be due 
TABLE  III 
I 
No. 
578 
0 
0 
0 
P fraction 31P s (Type II)  C fraction 7C  t (Type I-III) 
II 
No. 
551 
-~er 
-bar 
-4- 
III 
i 
NO. 
556 
IV  Polyvalcnt  I 
No.  No. 2  No. 
535  578 
0  .4-or  -4-~ 
0  4- ~  q-~ 
0  -4-  --I- 
o  ++++p  ± 
II 
No. 
551 
-bcr [ 
-4- 
-4- 
III  IV 
No.  No. 
556  535 
0  :~ 
0  -~ 
=F  4- 
Polyvalent 
No. 2 
++~ 
d+++~ 
+++d 
++++d 
Immedlate~ Ring 
1 hr.  J  test 
2 hrs. 
Ice box 
c =  cloudiness. 
r =ring. 
p  =  granular precipitate. 
d  =  firm disc. 
to some antigen other than those as yet isolated.  The antibodies for 
this antigen can be absorbed by using whole organisms, as was shown 
in Experiment 1. 
The specificity of the precipitin reaction between the type-specific 
substance and the monovalent sera can be brought out by a method 
other than that of absorption; namely, by dilution. 
Dilutions may be made either of the solution of type-specific sub- 
stance with the serum remaining constant, or of the serum with the 
dilution of type-specific substance remaining constant.  Under both 
of  these circumstances the titre is higher with the homologous sera 
(including Type III serum) and the amount of precipitate formed is 
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Experiment 3.--Dilutions  of the type-specific substance of Type I (Strain 428), 
which had been purified by reprecipitation, were made from 1/100 to 1/10,000. 
These were set up against undiluted  serum.  Serum dilutions were made from 
undiluted serum to 1 part in 32.  All dilutions were made in normal saline.  The 
serum dilutions were set up against a 1/1,000 solution of type-specific substance. 
The results are shown in Table IV. 
It will be noted that the specific precipitation occurs with dilutions 
of specific substance of 1/10,000 and undiluted  serum,  or with dilu- 
tions of serum of 1/32 and specific substance 1/1,000.  On the other 
hand, the heterologous reaction occurs only at 1/1,000 of specific sub- 
stance dilutions  and  1/8 of serum dilution.  Moreover,  the amount 
of precipitate  formed  in  the  cross-precipitation  is  throughout  more 
scanty.  It will further be seen that  the Type III antiserum gives a 
higher titre in both parts of the experiment than  the Type I  serum. 
The specimen of Type III antiserum used in this experiment had the 
highest titre of any rabbit monovalent serum prepared up to the time 
the experiment was carried out.  8 
The Type I  specific substance precipitates readily with some speci- 
mens of polyvalent antimeningococcal horse serum.  The titre reached 
is often higher  than  that obtained with the homologous monovalent 
rabbit serum. 
Experiment 4.--Dilutions  of the type-specific substance from 1/100 to 1/10- 
000,000 were set up against undiluted polyvalent antimeningococcal horse serum 
No. 3.  Dilutions of the serum from 1/1 to 1/32 were set up against type-specific 
substance diluted 1/1,000.  The precipitin test was carried out in the usual way. 
Table IV shows the final readings. 
It will be seen from Table IV that the type-specific substance pre- 
cipitates well with the particular sample of polyvalent antimeningococ- 
cal horse serum used in this experiment.  With dilutions of the specific 
substance itself, a  higher  titre is reached with the polyvalent serum 
than  with the homologous antisera,  while in  the serum dilutions  the 
titre is the same in both instances.  From this it might  appear that 
polyvalent  sera  contain  more  type-specific precipitins  than  do  the 
specifically prepared monovalent sera.  Absorption experiments, how- 
Specimens of Type I specific substance prepared more recently by improved 
chemical methods give a good precipitate in homologous sera at 1/1,000,000 and 
fail to precipitate with Type II or Type IV sera at 1/1,000. GEOFFREY  RAKE  AND  HENRY  W.  SCHERP 
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ever, prove that such is not the case, for heterologous strains or speci- 
mens of non-type-specific fractions will remove a larger part of these 
precipitins.  They are,  therefore, not  type-specific and  the precipi- 
tates formed represent in large degree reactions with impurities re- 
maining in the sample of type-specific substance. 
Two samples of polyvalent serum No. 3 were absorbed twice with 
large amounts of homologous (Type I,  Strain 454)  and heterologous 
(Type II, Strain 442) whole organisms for 2½ hours at 37°C. and over- 
night in the ice box.  The polyvalent absorbed sera were set up against 
dilutions of the type-specific substance.  Not  even the homologous 
absorption removed all the precipitins from the serum.  The heterol- 
ogous strain removed a large part of the precipitins, showing that they 
were group-specific rather than type-specific; yet the absorption with 
homologous organisms was even more complete, showing that a part 
of the precipitins  in  the polyvalent antimeningococcal horse  serum 
are, as might be expected, type-specific. 
The precipitin reaction between the type-specific substance and the 
monovalent rabbit  antiserum shows an inhibition zone in the lower 
dilutions.  This  phenomenon  is  brought  out  very  clearly  by  the 
method of precipitin test that has been used--namely, first a ring test 
and then mixing of the sera.  No zone phenomenon is shown by the 
ring test, but when lower dilutions of the type-specific substance have 
been used, reabsorption of the precipitate occurs in quite a dramatic 
manner directly the solution of specific substance and serum are mixed 
intimately. 
Experiment 5.--Dilutions of Type I specific  substance were  made from 1/40 to 
1/125.  These were set up against undiluted Type I monovalent serum and the 
precipitin test was carried out in the usual way. 
At the end of 1 hour at 37°C.,  there is no inhibition zone demon- 
strated by the ring precipitin test.  Directly on mixing, however, in 
the three lower dilutions all precipitate formed disappears completely, 
the precipitate in the fourth tube is decreased slightly, while that in 
the fifth tube, i.e.,  the highest dilution, remains unchanged.  At the 
end of the 2nd hour at 37°C.,  the first three tubes show very little 
precipitate.  The precipitate in  the fourth and fifth tubes is about 
equal.  After standing overnight in the ice box the amounts of pre- 
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The type-specific substance in a dilution of 1/100 gives a slight pre- 
cipitate  with  both  antigonococcal and  antipneumococcal Type  III 
sera.  There is no reaction at 1/1,000 or higher dilutions.  The reac- 
tion is without doubt due to the incomplete purification of the fraction. 
Chemical A nalysis.--A more detailed chemical study of the various 
fractions thus far isolated is being undertaken at present and the re- 
sults will be presented in a later paper (12).  Crude specimens of Type 
I  specific substance give a positive biuret test, a  precipitate with 20 
per cent trichloracetic acid and a Molisch reaction.  The most puri- 
fied specimen yet obtained, giving a precipitin reaction out to 1/10,000 
with homologous rabbit serum and  1/100,000  with polyvalent horse 
TABLE  V 
Setulll 
Dilutions  I  n  nI  IV 
No. 578  No. 551  No. 556  No. 535 
1/10 
1/2s 
1/so 
1/75 
1/100 
+++ 
+q--t- 
++ 
++ 
++ 
Saline--negative 
serum, showed the following on analysis.  A  Molisch reaction could 
be  obtained in a  dilution of 1/100;  and a  strong biuret  test  and a 
marked precipitate with trichloracetic acid were obtained in a  dilu- 
tion of 1/1,000, though both tests were negative at 1/10,000. 
Type II 
In this case also, most of the work has been carried out with a single 
specimen of type-specific substance obtained from Strain  31  in  the 
manner already described.  This strain showed a characteristic agglu- 
tination (Table V) in monovalent sera prepared with freshly isolated 
strains (1). 
The fraction gives a good precipitin reaction with homologous Type 
II monovalent rabbit  antiserum with rather less  cross-precipitation 354  MENINGOCOCCUS  INFECTION.  III 
than is obtained with the specimen of type-specific substance obtained 
from Type I.  A  noticeable feature is a  quite marked cross-precipita- 
tion  with  Type  IV  antiserum--more  marked  than  is  the  case with 
Type I  specific substance.  This suggestion of relationship of Type II 
to Type IV has been  noted several  times throughout the investiga- 
tions; owing, however, to the absence at the present time of a  freshly 
isolated Type IV strain, the serum used is not of the same value as that 
for Types I, II and III, nor can the problem be investigated further at 
the  moment.  Absorption  of  the  monovalent  sera  removes  all  the 
group precipitins and, it must be noted, removes the precipitins of the 
Type IV  serum. 
TABLE  VI 
No. 
578 
o 
+, 
+ 
+ 
Sera unabsorbed  Sera absorbed 
II  In 
No. 551  No.  556 
-k °"  0 
p+++"  +~ 
+++P  + 
IV 
No. 535 
o 
+:1=  ~ 
++p 
++pa 
I  II  III 
N¢~  No. 551  No.  555 
0  +~  0 
o  ++o~  0 
o  ++  o 
0  +++p  0 
IV 
No. 
535 
0  Immediate~ Ring 
0  1 hr.  J  test 
0  2 hrs. 
0  Ice box 
Experiment 6.--A purified specimen of Type II specific substance  is made up 
in a  dilution of 1 part in 100 of saline.  This is set up against unabsorbed and 
absorbed monovalent rabbit sera and the precipitin test carried out in the usual 
manner.  As in Experiment 1, the absorption was carried out both with dried C 
substance and with whole organisms, on this occasion of Type I (Table VI). 
As with Type I  specific substance, dilution of either the solution of 
specific substance or of the serum serves to bring out the specificity of 
the reaction. 
Experiment 7.--Dilutions of a purified specimen of Type II specific substance 
were made, ranging from 1/100 to 1/10,000,000.  These were set up against un- 
diluted serum.  Serum dilutions were made from undiluted serum to 1 part in 32 
and these were set up against a  l/l,000 solution of the specific substance (Table 
VII). 
It will be  noted that  the  type-specific substance  reacts  with  the 
homologous serum in a  dilution of 1/100,000 albeit slightly.  This is GEOFFREY  RAKE  AND  HENRY  W.  SCHER.P 
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to be compared with the high dilutions in which this same specific 
substance gives protein reactions (see below).  In the serum dilution 
protocol, the relationship of the Type IV to the Type II already men- 
tioned above is brought out quite sharply. 
As with the Type I  specific substance,  so the Type II reacts with 
some specimens of polyvalent antimeningococcal horse serum.  This 
reaction is due in part  to type-specific and in part to group-specific 
precipitins in the serum, as can be shown by absorption. 
Experiment &--Dilutions of Type II specific substance from 1/100  to  1/10- 
000,000 were set up against  undiluted polyvalent  serum No.  3.  Dilutions  of 
serum from undiluted up to 1/32 were set up against Type II specific substance 
diluted 1/1,000 (Table VII). 
As with the Type I  specific substance and polyvalent serum  (see 
Experiment 4)  so here also the precipitin reaction between Type II 
specific substance and  the particular  specimen of polyvalent  serum 
used reaches a high titre, slightly higher in fact in the serum dilutions 
for the polyvalent  than  for  the homologous Type II  serum.  Here 
again, however, it can be shown by absorption that the reaction is due 
in large part to the non-specific precipitins in the polyvalent serum 
precipitating impurities, including the non-specific polysaccharide C, 
remaining in the type-specific substance. 
Two samples of polyvalent serum were absorbed with homologous 
(Type II,  Strain 442)  and heterologous (Type I,  Strain  454)  whole 
organisms and set up against the dilutions of type-specific substance. 
Absorption with heterologous organisms removed a  large amount of 
the  antibodies  from the  serum,  showing them to  be group-specific; 
homologous absorption removed even more of the antibodies,  these 
obviously being those against the type-specific substance. 
Type II specific substance in a dilution of 1/100 gives a slight pre- 
cipitate with antigonococcal serum and a  still slighter reaction with 
antipneumococcal Type III serum.  No reaction occurs in a dilution 
of  1/1,000.  The reaction is due to the presence in the specimen of 
type-specific substance of some group- or non-specific fractions. 
Chemical Analysis.--Crude specimens of Type II specific substance 
give a positive biuret test, a  precipitate with 20 per cent trichloracetic 
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obtained, which gives a precipitin reaction with homologous serum in 
a  dilution  of  1/100,000,  gives a  positive  biuret  test  and  a  marked 
precipitate with trichloracetic acid at 1/1,000 and a slight precipitate 
with trichloracetic acid at  1/10,000.  The Molisch reaction is posi- 
tive at 1/100. 
Type III 
As has been mentioned above, the strain used in obtaining the Type 
III specific substance has been No. 302, secured from Dr. Sara Bran- 
ham of the Public Health Service,  Washington,  as  their  most nar- 
row!y specific Type III  strain.  Tested with the monovalent sera in 
TABLE  VIII 
Serul~ 
Dilutions  I  II  nI  IV 
No. 578  No. 551  No. 556  No. 535 
1/lO 
1/23 
1/50 
1/75 
1/100 
++++ 
++++ 
+++ 
++ 
+ 
+++ 
++ 
++ 
+ 
+ 
Saline--negative 
use in  this laboratory and using low dilutions in a 37°C. water bath, 
the  strain gave an agglutination very similar to that given by any 
other Type I or Group I-III strain which has been isolated for some 
months and subcultured on artificial media (Table VIII). 
Since this strain was not freshly isolated, it was to be expected that 
the yield of type-specific substance would be small, for this has been 
found to  decrease in  amount with the length of time the organism 
has been grown on artificial media (13).  This fact explains, no doubt, 
some of the morphological changes which are characteristic of the 
transformation from "fresh" to  "stock"  cultures  (14),  and also  the 
well recognized fact that stock strains usually show a loss of their type 
specificity as judged by the agglutination test  (especially when that 
test is carried out at 55°C.).  The total yield from this strain was 75 358  MENINGOCOCCUS  INFECTION.  III 
rag. of dried purified material.  Of this, 55 rag. were obtained in the 
usual manner described above for isolation of type-specific substance. 
This specimen contained other substances which gave cross-precipita- 
tion with Type II and Type IV serum in the same way as the speci- 
mens of Type I  and Type II specific substance gave cross-precipita- 
TABLE  IX 
Serum 
II  III 
No. 592  z  No. 266 
0  +++d 
IV 
No. 578  No. 577 
No. 302 specific substance 1/250  .~-.~-.~-d  0 
TABLE  X 
Dilutions of serum 
Serum 
Type I 
serum 
Type llI 
serum 
Dilutions of type-specific substance 
1/250  lO-S  lO-t  104  lO'-e  10  -7 
+++p  +++p  ++p  o  o  o 
Serum 
! Type I 
serum 
Type III 
serum 
1/1  1/2  1/4  1/8  1/16 1/32 
+++P  +++P  ++P  +P  o  o 
-~--~--I-P -I---]--]-P -~-Jr-~-P -~--~-P --~p  ::F 
TABLE  XI 
Serum  ............. 
Absorbed with  ..................... 
Type I specific substance 
1/2oo 
Type III specific substance 
1/250 
I  I 
I  nI 
o  o 
o  o 
ni 
i 
o 
o 
III  I  III 
III  -  -- 
0  .~--~ pd  -]--I_ .Jcpd 
0  ++_{_d  +++d 
tion.  The other 20 rag. were obtained from the nucleoprotein frac- 
tion or P  which had been precipitated with  10 per cent acetic acid. 
This P  fraction was found to contain not inconspicuous amounts of 
the type-specific fraction when it was tested with monovalent sera.  It 
has been noted throughout the work that the nucleoprotein fraction 
contained varying amounts of type-specific substance which could be 
removed only with great difficulty.  As a  rule the amount was very GEOFFREY  RAKE  AiN-D HENRY  W.  SCHERF  359 
small  but in  the present  case it  was quite considerable.  As a  con- 
sequence, it was precipitated with two volumes of ethyl alcohol and a 
scanty yield of  type-specific  substance  obtained.  The  important 
feature  about  the  type-specific  substance  secured  in  this  way  was 
the absence of impurities  giving any  significant  cross-precipitations 
with Type II and Type IV sera (Table IX). 
Titrations of the specific substance show that it behaves in a manner 
almost identical with that of the Type I  specific substance.  It gives 
a  positive reaction with both Type I  and Type III serum out to  1/- 
10,000 but not to 1/100,000, and in dilutions of 1/1,000 it reacts with 
Type I serum diluted 1/8 and Type III serum diluted 1/32 (Table X). 
Chemical analysis of the Type III specific substance fails to show 
any  differences from  the  analysis  of  the  Type I  fraction.  Thus,  a 
purified  specimen gives a  positive Molisch reaction  at  1/100,  and  a 
strong biuret test and a good precipitate with 20 per cent trichlorace- 
tic  acid  are  demonstrable  in  a  dilution  of  1/1,000  though  both  are 
negative at 1/10,000. 
• An even more intimate  relationship  between the specific fractions 
is brought out by means of absorption experiments. 
Experiment 9.--Samples  of Type I and Type III serum  were absorbed  with 
whole organisms of both Type I  and  Type III  strains.  The  organisms were 
left in contact with the serum for 2½ hours at 37°C. and 18 hours at the tempera- 
ture of the ice box.  These absorbed sera together with unabsorbed controls were 
then  set up against specimens of specific substance from Strains 428  (Type  1) 
and 302 (Type III).  The results are shown in Table XI. 
It  will be seen  that  the  absorption  of either  Type I  or Type ItI 
serum  by either  Type I  or Type III whole organisms  removes com- 
pletely  the  precipitins  in  these sera for both Type I  and  Type III 
specific  substances.  It  has  been  demonstrated  elsewhere  (see Ex- 
periments  1  and  6)  that,  when  strain  of organisms  and  serum  are 
heterologous,  absorption  with  whole organisms  helps  to remove the 
non-specific antibodies in the serum but leaves untouched the heterol- 
ogous  precipitins  for  the  type-specific  substance.  One  can  only 
conclude, therefore, from the above experiment  (Experiment  9)  that 
the type-specific substances isolated from the Type I and the Type III 
strains must be very similar in constitution  if they be not identical. 360  M'ENINGOCOCCUS  IN~'ECTION.  III 
The result of the absorption test agrees with the results obtained by 
other means which, as Tables I,  II,  IV,  VIII, IX,  X  and XI have 
shown, tend to prove the identity of the two substances. 
SII~MARY 
Three  fractions  have been  isolated  from auto]ysates  of  the  meningo- 
coccus.  Of  these,  one,  the  type-specific  substance,  has  been  described 
in detail. The same type-specific  substance appears to be present  in 
Type I and Type III organisms, but a substance differing  at least 
serologicaUy has been obtained from  Type  II  strains. Detailed 
chemical analysis of both of the type-specific substances thus far iso- 
lated is being carried out and will be the subject of a later paper. 
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